Skip to main content Skip to secondary navigation

Docket #: S11-477

Fertility treatment to stimulate ovarian follicles by inhibiting Hippo signaling

Researchers in Prof. Aaron Hsueh's laboratory have discovered a technique to promote fertility by stimulating the growth of ovarian follicles (functional units that produce oocytes) through disrupting the Hippo signaling pathway. The conserved Hippo pathway normally functions to maintain optimal size across organs and species. Disrupting the pathway in the ovaries (either through direct or downstream inhibitors) promotes the growth of follicles that can then be induced to produce mature oocytes through conventional FSH and hCG treatments. This approach has both human and veterinary applications and may be particularly well-suited for treating conditions of diminished ovarian reserve (such as primary ovarian insufficiency, polycystic ovary syndrome, or peri-menopause).

Applications

  • Human infertility treatment - therapeutic agents that inhibit Hippo signaling (including HSP90 inhibitors, PTEN inhibitors or PI3 kinase activators) to stimulate ovarian follicles for obtaining oocytes from patients with:
    • polycystic ovary syndrome
    • primary ovarian insufficiency
    • peri-menopause
  • Veterinary medicine - stimulate ovarian follicles to obtain mature oocytes in farm animals or endangered species

Advantages

  • Alternative to standard treatment - Hippo signaling inhibitors may provide an alternative to patients who do not respond to conventional FSH treatment because they have few follicles

Publications

Patents

Similar Technologies

Explore similar technologies by keyword: